Program Description: 
This is a multidisciplinary discussion including staging, prognostic indicators, and national treatment guidelines as outlined by the NCCN or other American College of Surgeons (ACoS) approved guideline. Improve the care of patients with cancer by providing multidisciplinary treatment planning and contribute to physician and allied medical staff education.
 
ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and Wheaton Franciscan Healthcare. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity a maximum of 1.0 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

 

Nurse Practitioner Accreditation Statement: 
The Medical College of Wisconsin is accredited by the American Association of Nurse Practitioners as an approved provider of nurse Practioner continuing education.  Provider Number: 150930.

Nurse Practitioner Credit Designation Statement:
Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 150930.  This program has been approved for 1.0 contact hours of continuing education (which includes 0.0 hours of pharmacology).
Target audience: 
  • Physicians
  • Allied Health Professionals
Learning objectives: 

At the conclusion of this activity, I will be able to:

  • Evaluate clinically relevant, rarely occurring and/or complex cancer cases in a multidisciplinary setting
  • Discuss cancer cases, indicate clinical stage, prognostic indicators of the tumor and treatment guidelines based on NCCN guidelines or other ACoS approved guidelines
  • Assess new modalities relative to the treatment of cancer
Faculty & credentials: 
Planning Committee:
Dr. Shannon Offerman
Dr. Leena Maramattom Varkey
Anne Hanson
Jeanette Frawley
Dr. Joseph Battista
 
Presenter:
Dr. Shannon Offerman
Dr. Leena Maramattom Varkey
Dr. Kate Hallenbeck
Dr. Jeanne Hryciuk
Dr. Francis Cuevas
Dr. Therese Kerwel
Dr. James Burhop
Dr. Bobby Wu
Dr. Joseph Battista
Dr. Ryan Berg
 

No one in control of content has any relevant financial relationship to disclose, except for the following:

 
NameCompanyRole
Dr. Kate HallenbeckMDI (Medical Diagnostic ImagingOwner
   

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

Contact

Name: 
Briana Prudhomme
Phone number: 
+1 (262) 687-5018
Session date: 
03/02/2017 - 7:30am to 8:30am CST
Location: 
Elmbrook Memorial Hospital
19333 W North Ave
Brookfield, WI 53045
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
  • 1.00 NP Contact Hours

Please login or register to take this course.